BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14558009)

  • 1. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
    Chen Z; Lu L; Zhang H; Dean NM; Fung JJ; Qian S
    Microsurgery; 2003; 23(5):494-7. PubMed ID: 14558009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
    Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
    Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus.
    Tao R; Wang L; Chen CH; Wang SH; Demarco RA; Lotze MT; Thai NL; Fung JJ; Lu L; Qian S
    J Heart Lung Transplant; 2006 Mar; 25(3):310-9. PubMed ID: 16507425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.
    Giannoukakis N; Bonham CA; Qian S; Chen Z; Peng L; Harnaha J; Li W; Thomson AW; Fung JJ; Robbins PD; Lu L
    Mol Ther; 2000 May; 1(5 Pt 1):430-7. PubMed ID: 10933964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S
    Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effect of nuclear factor-κB inhibition by dehydroxymethylepoxyquinomicin in combination with donor-specific blood transfusion.
    Goto R; Yamashita K; Aoyagi T; Ueki S; Uno M; Oura T; Kobayashi N; Igarashi R; Shibasaki S; Wakayama K; Hirokata G; Shibata T; Zaitsu M; Umezawa K; Ozaki M; Todo S
    Transplantation; 2012 Apr; 93(8):777-86. PubMed ID: 22357176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities.
    Stepkowski SM; Tu Y; Condon TP; Bennett CF
    J Immunol; 1994 Dec; 153(11):5336-46. PubMed ID: 7963586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of the role of the NF-kappaB family of transcription factors during alloimmunity.
    Finn PW; He H; Ma C; Mueller T; Stone JR; Liou HC; Boothby MR; Perkins DL
    J Leukoc Biol; 2002 Nov; 72(5):1054-62. PubMed ID: 12429729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells.
    Xu DL; Liu Y; Tan JM; Li B; Zhong CP; Zhang XH; Wu CQ; Tang XD
    Scand J Immunol; 2004 Jun; 59(6):536-44. PubMed ID: 15182248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.
    Tiao MM; Lu L; Tao R; Wang L; Fung JJ; Qian S
    Ann Surg; 2005 Mar; 241(3):497-505. PubMed ID: 15729074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
    Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
    J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
    J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses.
    DeBruyne LA; Li K; Chan SY; Qin L; Bishop DK; Bromberg JS
    Gene Ther; 1998 Aug; 5(8):1079-87. PubMed ID: 10326031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
    Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
    J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
    Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
    J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival.
    Huang BJ; Yin H; Huang YF; Xu JF; Xiong P; Feng W; Zheng F; Xu Y; Fang M; Gong FL
    Transpl Immunol; 2006 Aug; 16(2):88-94. PubMed ID: 16860710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse.
    Bueno V; Binet I; Steger U; Bundick R; Ferguson D; Murray C; Donald D; Wood K
    Transplantation; 2007 Nov; 84(9):1204-7. PubMed ID: 17998878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.